Resmed announced the election of Nicole Mowad-Nassar to its board of directors effective August 15, 2025.
Nicole Mowad-Nassar brings over 30 years of strategic and operational expertise in the pharmaceutical industry, focusing on digital innovation.
Rich Sulpizio, a board member for two decades, will retire from Resmed following the 2025 Annual Meeting of Stockholders in November.
Nicole Mowad-Nassar's Expertise
Over 30 years of experience in senior executive roles with a focus on digital innovation and strategic planning.
Rich Sulpizio's Contribution
Served on Resmed's board since 2005, chaired the Compensation Committee, and provided valuable insights for tech and healthcare industries.
- Nicole Mowad-Nassar's appointment adds a new perspective of thought and healthcare experience to Resmed's board.
- Rich Sulpizio's retirement marks the end of two decades of significant contributions to Resmed's board, leaving a legacy of mentorship and leadership.
The addition of Nicole Mowad-Nassar and the retirement of Rich Sulpizio reflect Resmed's commitment to enhancing its board's expertise and leadership progression.